Picture of IR-MED logo

IRME IR-MED Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m+36.88%
3m+35.32%
6m+30.2%
1yr+193.9%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-9.75%
50d MA+23.54%
200d MA+10.22%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-470.43%
Return on Equity-239.16%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of IR-MED EPS forecast chart

Profile Summary

IR-Med, Inc. is a development-stage medical device company. The Company develops non-invasive devices for various medical indications, by detecting and measuring various biomarkers and molecules in the blood and in human tissue in real-time. The Company’s devices allow healthcare professionals to detect and measure different molecules in the blood and in human tissue in real-time without any invasive procedures. Its initial product candidates are in various stages of development. It is focused on two principal medical devices: PressureSafe and Nobiotics. PressureSafe is a handheld optical monitoring device that is being developed to support the early detection of pressure injuries (PI) to the skin and underlying tissue, primarily caused by prolonged pressure associated with bed confinement. Nobiotics is an otoscope, which is designed to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media) is of a bacterial origin.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    April 20th, 2007
    Public Since
    July 18th, 2001
    No. of Employees
    7
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    69,924,240

    IRME Share Price Performance

    Upcoming Events for IRME

    Similar to IRME

    Picture of Aamaxan Transport logo

    Aamaxan Transport

    us flag iconPink Sheets on Nasdaq

    Picture of ACCUSTEM SCIENCES logo

    ACCUSTEM SCIENCES

    us flag iconPink Sheets on Nasdaq

    Picture of ADM Tronics Unlimited logo

    ADM Tronics Unlimited

    us flag iconPink Sheets on Nasdaq

    Picture of Aksys logo

    Aksys

    us flag iconPink Sheets on Nasdaq

    FAQ